Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / April / Optimizing the Ocular Surface Before and After Cataract Surgery
Discussion Anterior Segment Cataract

Optimizing the Ocular Surface Before and After Cataract Surgery

The role of perfluorohexyloctane in dry eye management

By Justin Schweitzer 4/8/2026 3 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions
  • Top Thought Leaders
Top Institutions in Ophthalmology

Institutions leading in ophthalmology research and clinical care, especially those with dedicated cornea and external disease divisions, are recognized for their expertise in ocular surface disease and cataract surgery optimization. Their methodologies typically include clinical trials, translational research, and advanced surgical techniques to improve patient outcomes.

  • #1

    Bascom Palmer Eye Institute

    Miami, FL

    Bascom Palmer is consistently ranked as the top ophthalmology center in the US, with extensive research and clinical programs focused on ocular surface disease and cataract surgery outcomes. Their cornea division leads numerous clinical trials on dry eye disease and ocular surface optimization.

    Key Differentiators

    • Ophthalmology
    • Cornea and External Disease
    • Cataract Surgery
  • #2

    Massachusetts Eye and Ear Infirmary

    Boston, MA

    Massachusetts Eye and Ear has a strong research focus on ocular surface diseases and cataract surgery, with a robust clinical trials program evaluating novel therapies for dry eye and optimizing surgical outcomes.

    Key Differentiators

    • Ophthalmology
    • Cornea and External Disease
    • Refractive Surgery
  • #3

    Johns Hopkins Wilmer Eye Institute

    Baltimore, MD

    Wilmer Eye Institute is renowned for its comprehensive approach to ocular surface disease and cataract surgery, integrating clinical care with translational research to improve patient outcomes in dry eye and refractive surgery.

    Key Differentiators

    • Ophthalmology
    • Cornea and External Disease
    • Cataract Surgery
  • #4

    Duke Eye Center

    Durham, NC

    Duke Eye Center has a strong clinical and research focus on ocular surface disease and cataract surgery, with active participation in clinical trials evaluating new treatments for dry eye and surgical optimization.

    Key Differentiators

    • Ophthalmology
    • Cornea and External Disease
    • Cataract and Refractive Surgery
  • #5

    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    UCSF is a leading academic center with strong research and clinical programs in ocular surface disease and cataract surgery, contributing to advancements in dry eye management and surgical outcomes.

    Key Differentiators

    • Ophthalmology
    • Cornea and External Disease
    • Cataract Surgery

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: